Home › Evonik Industries and OPX Biotechnologies to Develop Bio-Based Chemicals
 

Keywords :   


Evonik Industries and OPX Biotechnologies to Develop Bio-Based Chemicals

2013-05-14 06:00:00| Chemical Processing

OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced May 14 that the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement calls for OPXBIO to use its EDGE (Efficiency Directed Genome Engineering) technology to develop the bio-processes.

Tags: develop industries chemicals biotechnologies

Category:Chemicals

Latest from this category

All news
31.10Nippon Paint Holdings to Acquire AOC from Lone Star Funds
31.10RPM Acquires TMP Convert
31.10AkzoNobels Largest European Solar Energy Plant Goes Live in Poland
30.10BASF Groups EBITDA Before Special Items Up from Q3 2023
30.10Axalta Reports Record Net Sales in 3Q 2024
30.10Zack Hays Joins Orion S.A. as Marketing Manager
30.10UK Linseed Paint Maker Launches US Venture
29.10Grand Prairie, Texas is Tnemecs 2024 Tank of the Year Winner
Chemicals »
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11How Japan's youngest CEO transformed Hello Kitty
31.10Unicharm to Expand in Africa
More »